AI Science Tracker
EN

Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA

1 discovery from 2022

Discoveries

Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Primary BMC Cancer Methods/Results describe CancerOmicsNet deep graph learning over cancer-specific networks and literature-selected unseen predictions; live-cell time-course assays were run in breast, pancreatic and prostate cancer cell lines. The bounded result is a set of predicted inhibitor effects with cell-line assays, not patient treatment efficacy.

Technology: Attention-based deep graph model predicts effects of multitargeted kinase inhibitors from heterogeneous cancer-network data.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Attention-based deep graph model predicts effects of multitargeted kinase inhibitors from heterogeneous cancer-network data.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12885-022-10293-0

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.